IDO1 and neoplasm: Here, we extended the pro-tumorigenic adverse effect of IDO1 catalytic inhibition to different human IDO1-expressing tumor cell lines, dissecting the signaling pathway mediated by IDO1 and proposing IDO1 protein degradation as an effective approach to neutralize the dual function of IDO1 in cancer.